A medida que los fabricantes de productos farmacéuticos buscan soluciones novedosas para afecciones complejas, los cannabinoides -especialmente el cannabidiol (CBD)- se perfilan como candidatos prometedores para la innovación farmacológica. Gracias a la evolución favorable de la normativa y al aumento de las pruebas científicas que avalan su potencial en el tratamiento de trastornos del sistema nervioso central, el dolor y el cáncer, los cannabinoides están llamados a ampliar las posibilidades terapéuticas. Este libro blanco explora las últimas investigaciones sobre los cannabinoides y destaca cómo dsm-firmenich colabora con la industria farmacéutica para impulsar el desarrollo de fármacos en las primeras fases de este apasionante campo. Descargar para saber más sobre el avance de las terapias basadas en cannabinoides.
Discover how dsm-firmenich and ten23 health are transforming biologic formulation development through advanced excipient options.
Explore what newly published CBtru® pharmacokinetic data means for solid oral drug development—and why clinical evidence underpins meaningful innovation.
Discover how pharmaceutical quality management is advancing through proactive strategies that reduce risk, improve visibility, and support compliance.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.